News

[ scream it from the rooftops ]

TRHC’s CareKinesis Creates First Science-Based Personalized Medication Risk Score

Moorestown, NJ (August 15th 2017) – CareKinesis, a division of Tabula Rasa HealthCare (NASDAQ:TRHC), a medication risk management services and comprehensive PACE-focused pharmacy, is launching the first science-based total Medication Risk Score that will help clinicians pinpoint areas to improve medication quality and safety. The Medication Risk Score serves as... Read More

Hope HealthCare Executive Appointed to TRHC Board of Directors

Moorestown, NJ (August 9, 2017) – Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital software solutions and novel, proprietary medication decision support tools, appointed Samira Kanaan Beckwith, LCSW, FACHE, LHD, to its Board of Directors on August 3,... Read More

TRHC Selected by PACE of the Triad, Adding its Fourth PACE client in NC

Moorestown, NJ (August 3, 2017) – Tabula Rasa HealthCare (NASDAQ: TRHC) President and Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD, MBA announced TRHC subsidiary company CareKinesis has been selected to provide its comprehensive Medication Risk Mitigation by CareKinesis® and PACE-focused pharmacy services to PACE of the Triad,... Read More

TRHC to Provide Care Transition Medication Management for Tandigm Health

Moorestown, NJ and West Conshohocken, PA – June 20, 2017 – Tabula Rasa HealthCare (NASDAQ:TRHC), a healthcare technology company optimizing medication safety by deploying novel Medication Risk Mitigation digital solutions and Medication Decision Support tools, and Tandigm Health, LLC, a value-based healthcare company supporting primary care physicians, announced today that... Read More

TRHC and Landmark to Improve Patient Outcomes in California and New York

MOORESTOWN, N.J. and HUNTINGTON BEACH, Calif., May 01, 2017 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company disrupting the field of medication safety, has licensed the use of its medication risk mitigation platform, MedWise Advisor®, to Landmark, a leading national medical group focused exclusively on the... Read More